Literature DB >> 27544338

Evacuating Hypertensive Intracerebral Hematoma with a Cortical Sulcus Approach.

Zhibo Gao1, Lingtao Qian2, Chaoshi Niu3, Bin Chen2, Hongjun Guo2, Pengju Sun2, Yongzhi Wang2, Liang Ning2, Qi Li2, Xianming Fu4.   

Abstract

OBJECTIVE: To study the curative effect and prognosis of patients with basal ganglia cerebral hemorrhages treated using a transcortical-sulcus approach and compare with results obtained using the traditional cerebral cortex approach.
METHODS: Clinical data were collected from 106 patients with hypertensive hemorrhage in the basal ganglia who were treated using either a transcortical-sulcus approach or traditional cerebral cortex approach. The rate of rehemorrhage, incidence of epilepsy, and 3-month efficacy (defined by an activities of daily living score) rate between the 2 groups were compared.
RESULTS: The 3-month efficacy rates of patients treated using the transcortical-sulcus and traditional cerebral cortex surgical approaches were 78.4% and 60%, respectively (P < 0.05). The incidence of epilepsy was lower in the transcortical-sulcus approach group compared with the traditional approach group, and significant differences were detected between the 2 groups (P < 0.05).
CONCLUSIONS: The transcortical-sulcus approach can significantly improve the prognosis of patients with intracerebral hemorrhages in the basal ganglia and reduce the incidence of postoperative seizures.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Hypertensive; Intracerebral hemorrhage; Transcortical-sulcus approach

Mesh:

Year:  2016        PMID: 27544338     DOI: 10.1016/j.wneu.2016.08.030

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Experience of Using a New Brain Surgery Head Frame and Location Sticker for Treating Spontaneous Intracranial Hematoma.

Authors:  Hongyu Wang; Wenqiang Xin; Jianzhong Cui
Journal:  Front Neurol       Date:  2022-04-27       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.